ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Maat Pharma SA

Maat Pharma SA (MAAT)

9.06
0.00
(0.00%)
Closed April 28 11:30AM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
9.06
Bid
8.90
Ask
9.06
Volume
174
9.00 Day's Range 9.06
4.50 52 Week Range 9.90
Market Cap
Previous Close
9.06
Open
9.06
Last Trade
7
@
9.06
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,628
Shares Outstanding
11,616,199
Dividend Yield
-
PE Ratio
-5.34
Earnings Per Share (EPS)
-1.7
Revenue
2.23M
Net Profit
-19.72M

About Maat Pharma SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Lyon, Rhone, Fra
Founded
1970
Maat Pharma SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker MAAT. The last closing price for Maat Pharma was 9.06 €. Over the last year, Maat Pharma shares have traded in a share price range of 4.50 € to 9.90 €.

Maat Pharma currently has 11,616,199 shares outstanding. The market capitalization of Maat Pharma is 105.24 € million. Maat Pharma has a price to earnings ratio (PE ratio) of -5.34.

MAAT Latest News

MaaT Pharma annonce la tenue de son Assemblée Générale Mixte le 28 mai 2024

Regulatory News: MaaT Pharma (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem TherapiesTM (MET)1...

MaaT Pharma Presents Positive 18-month Data for MaaT013 Showing a Clear Overall Survival Advantage in aGvHD from the Early Access Program at the 2024 EBMT Event

Positive efficacy and safety results in 140 patients treated with MaaT013 in acute graft-versus-host disease (aGvHD) as part of the MaaT Pharma Early Access Program (EAP). Gastrointestinal...

MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital

Article 223-16 of the General Regulations of the Financial Markets Authority (AMF - Autorité des Marchés Financiers) Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a...

MaaT Pharma présente des données précliniques prometteuses à l'AACR pour MaaT034 visant à améliorer les réponses des patients aux immunothérapies

Regulatory News: MaaT Pharma (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem TherapiesTM (MET)1...

MaaT Pharma annonce l’initiation de la couverture de son titre par Gilbert Dupont / Groupe Société Générale

Regulatory News: MaaT Pharma (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem TherapiesTM (MET)1...

MaaT Pharma publie ses résultats annuels pour l’année 2023 et fait un point sur ses activités

Le DSMB, sur la base des résultats préliminaires de l'essai de Phase 3 ARES, a conclu que MaaT013 a un rapport bénéfice/risque favorable avec "une efficacité élevée et une faible toxicité" dans...

MaaT Pharma Strengthens Executive Team Appointing Jonathan Chriqui as Chief Business Officer

Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to...

MaaT Pharma présentera de nouvelles données précliniques à l'AACR pour MaaT034 visant à améliorer les réponses des patients aux immunothérapies

Le poster présentera la caractérisation des métabolites produits par MaaT034 ainsi que ses effets immunomodulateurs sur les cellules de l’hôte. Les nouvelles données renforcent les résultats...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.080.8908685968828.989.068.612148.79475037DE
40.262.954545454558.89.98.616789.15742029DE
121.7624.10958904117.39.96.8816288.6667398DE
262.7643.80952380956.39.96.315897.84797227DE
52-0.66-6.790123456799.729.94.514367.19274749DE
156-4.44-32.888888888913.514.44.512739.75900083DE
260-4.44-32.888888888913.514.44.512739.75900083DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

Discussion

View Full Feed
Doc logic Doc logic 2 minutes ago
learningcurve2020,

Why? Don’t you like my nice bright tie dye colors I painted the cabal with?; ).
NWBO
Carjockey2 Carjockey2 2 minutes ago
I'm sorry what??

What's rocky?
IGPK
delerious1 delerious1 2 minutes ago
Stay up 'til 1:30 and let us know...LOL
IGPK
Bizdevguy Bizdevguy 3 minutes ago
Yes sir
AABB
Dodger1 Dodger1 3 minutes ago
Wow, like I think they have all they can get and no more loans unless credit worthy....that the DTC? And Bitcoin targeted...so looks like only niche people own that in the end?

Crooked from the top down...and now the squeeze
DTC
waterchaser waterchaser 3 minutes ago
You can continue repeating lies about me all you want.

I’m not paid by anyone…anybody…to expose scam puffers like you.

I’m comfortably retired and I enjoy my hobby of pissing you and other scammers off.

Carry on, scam clown pumper.
VNUE
Dyno89 Dyno89 4 minutes ago
Gonna be an ugly Monday if those filings aren’t up and posted by 930. Does not take this long, so this is a company issue and not some otcmarkets issue on their end.
IGPK
skitahoe skitahoe 4 minutes ago
Powerwalker, clearly they'll be speaking with a quarterly in the next two weeks, but how much they can reveal above and beyond a normal quarterly may be in others hands. If no material or data that's never been peer reviewed is released, they're limited about what they can say. On the other hand,
AVXL
LuckyLovie LuckyLovie 5 minutes ago
Atleast Gs gives the news never late...NOT LIKE THE CHINESE ECOMERCE SCAM....POOR SHEEP with millions of shares list monies, WAITING FOR NEWS WITH ANOTHER EXCUSE....JHF OHHH WEEZ ON DIFF TIME ZONES WE FORGOT...NO WORRYS WE GO TO EXPWERT MARKET...CAUSE WEZ EXPWERTS WE BETTER THAN WALMART & ALIBABA CO
GVSI
$theDDmessiah $theDDmessiah 5 minutes ago
Yes
AGBA
TRAPPER JIM TRAPPER JIM 5 minutes ago
Yes ma’am. I’m going to call the corporate office tomorrow around 10-11 if I haven’t heard from them by then
TRUISM TRUISM 5 minutes ago
Hey Banana; guess what?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=129574613 YOU WERE SUPPOSED TO SELL IN 2018

bananarama
Re: cjstocksup post# 97328
Thursday, March 16, 2017 10:22:35 AM
Post# of 211605 Go
CJ,
KBLB
sicofbs sicofbs 6 minutes ago
So far it’s … well let’s just say a very rocky start
IGPK
TRAPPER JIM TRAPPER JIM 6 minutes ago
I hope so too
zulual zulual 6 minutes ago
Actually, I have updated my new address in my brokerage account, do I need inform any other party as well?
COOP
MrPuff MrPuff 6 minutes ago
He just got paid for your direct post to him. He’s a paid basher, that’s why he’s here. My recommendation, do not reply directly to him. He won’t make money and hopefully he’ll leave.
VNUE
Hercules1 Hercules1 6 minutes ago
i dont know why i kept calling it a bloody otc merger.

so used to seeing those reverse mergers on otc.


but anyway this is a NASDAQ deal.


and it is a very big deal.
AGBA
littlejohn littlejohn 7 minutes ago
SQQQ next target entry on Wednesday afternoon...

Amzn reports Tuesday and could

push it up a lil more...

AMD also reports and seems likely

a potential disappointment...

SQQQ target entry on Wednesday would

be i
AMD SQQQ
Eli-316 Eli-316 7 minutes ago
To all those that have expressed their gratitude since the announcement of this Q & A, you're welcome.

Let's hope Logan gives us clear, concise and honest answers that will clear up many questions that we've been guessulating about for months.

with miners mining 24/7
CGAC
gkare gkare 7 minutes ago
Someone please post it on X. I don't do X.
BIEI
Dyno89 Dyno89 7 minutes ago
Since BGEN and the assets under it were not part of the SAGA deal after all, and those clearly left with Charles and Chandra, the best anyone could hope for here (if the court was to decide the SAGA deal was not legal) is that ITV-1 and IPF (assets under VIRO) would come back under ENZC. And even th
ENZC
uber darthium uber darthium 7 minutes ago
Living rent free in your head…Not only so we have every post but it appears so do you. I remember reading that RB post almost like yesterday.

While we are reminiscing, why do you take the readers back to your “double cover naked short” theory ? Include the SGGM pump too. I wonder
MONI
Vector93 Vector93 8 minutes ago
Any idea why I can’t see L2 data for DKSC? I can see it for any other stock, but not this one.
DKSC

Your Recent History

Delayed Upgrade Clock